scispace - formally typeset
Open Access

Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission

TLDR
Risk of perinatal HIV transmission was low and no benefit from additional intrapartum/newborn nevirapine was demonstrated when women received prenatal care and antenatal ART, and elective cesarean section was made available.
About
The article was published on 2017-01-01 and is currently open access. It has received 368 citations till now. The article focuses on the topics: Nevirapine.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Mother to child transmission of HIV infection in the era of highly active antiretroviral therapy

TL;DR: The results suggest that offering an elective Caesarean section delivery to all HIV-infected women, even in areas where HAART is available, is appropriate clinical management, especially for persons with detectable viral loads.
Journal ArticleDOI

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

TL;DR: A single dose of nevirapine to the mother, with or without a dose ofNevirapin to the infant, added to oral zidovudine prophylaxis starting at 28 weeks' gestation, is highly effective in reducing mother-to-child transmission of HIV.
Journal ArticleDOI

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection

TL;DR: To assess which antiretroviral therapies may be effective in decreasing the risk of mother-to-child transmission of HIV infection as well as their effect on neonatal and maternal mortality and morbidity, the Cochrane Controlled Trials Register and conference abstracts were searched.
Journal ArticleDOI

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

TL;DR: Low maternal plasma viral load is the key factor for preventing mother-to-child HIV-1 transmission from mothers receiving antenatal antiretroviral therapy, and benefits in terms of MTCT reduction may be expected from early antireTroviral prophylaxis.
References
More filters
Journal ArticleDOI

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1

TL;DR: Lamivudine-zidovudine prophylaxis therapy may be effective in preventing maternal-infant HIV transmission, however, severe adverse effects and emergence of resistance to lamivUDine occurred.
Related Papers (5)

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

W. Andiman, +467 more